The global cryoablation devices market was valued at USD 183.89 million in 2022 and it is predicted to surpass around USD 418.09 million by 2032 with a CAGR of 8.56% from 2023 to 2032.
Cryoablation devices offer various benefits such as fewer side effects, easy recovery, cost-effective, etc. These benefits represent lucrative growth opportunities for the cryoablation market. In addition, new product launches and various studies being carried out by the government authorities, to broaden the application of cryoablation is also driving the growth of the market. For instance, November 2019, National Cancer Institute, launched the study to determine the effect of cryoablation on adaptive resistance to immunotherapy in metastatic cancer patients.
Report Scope of the Cryoablation Devices Market
Report Coverage | Details |
Market Size in 2022 | USD 183.89 million |
Revenue Forecast by 2032 | USD 418.09 million |
Growth rate from 2023 to 2032 | CAGR of 8.56% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Increasing prevalence of cancer such as lung and prostrate cancer and cardiac arrhythmia is another major factor boosting the growth of cryoablation market. According to study published by CDC, in October 2022, an estimated 12.1 million U.S. citizens will have Atrial Fibrillation in 2030. On the other hand, according to the American Society of Clinical Oncology, in 2020, an estimated 1.4 million men were diagnosed with prostate cancer, globally.
Increasing preference for minimally invasive surgeries is another factor driving the growth of the market. Preference for a good cosmetic outcome has led to shift towards breast-conserving, minimally invasive procedures such as radiotherapy and ablation therapies instead of surgery.
Based on application, the cardiac arrhythmia segment is expected to experience maximum growth owing to increasing prevalence and rising efforts of manufacturers to develop and expand the application of their products to treat this condition. While the breast cancer segment dominated the market due to increasing adoption of cryoablation devices in treatment of breast cancer.
Key players operating in the cryoablation devices market includes Boston Scientific, MicroPort Scientific Corporation, Medtronic Plc., CooperSurgical Inc., AtriCure Inc., Galil Medical, BVM Medical Limited, CPSI Biotech, HealthTronics, Inc., IceCure Medical and METRUM CRYOFLEX Sp. Manufacturers in the Market are focusing on launching new products in the market and expanding the application of the products that are already a part of their product portfolio. For instance, In February 2022, Medtronic Plc, received an expanded FDA approval for its Freezorand FreezorXtra Cardiac Cryoablation Focal Catheters to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).
Cryoablation Devices Market Segmentations:
By Product | By Application | By End-Use |
Tissue Contact Probe Ablators Epidermal and Subcutaneous Cryoablation Systems Tissue Spray Probe Ablators |
Lung Cancer Liver Cancer Breast Cancer Kidney Cancer Prostate Cancer Cardiac Arrhythmia |
Hospitals Ambulatory surgical centers Specialty Clinics Others |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Product Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cryoablation Devices Market
5.1. COVID-19 Landscape: Cryoablation Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Cryoablation Devices Market, By Product
8.1. Cryoablation Devices Market, by Product, 2023-2032
8.1.1 Tissue Contact Probe Ablators
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Epidermal and Subcutaneous Cryoablation Systems
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Tissue Spray Probe Ablators
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Cryoablation Devices Market, By Application
9.1. Cryoablation Devices Market, by Application, 2023-2032
9.1.1. Lung Cancer
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Liver Cancer
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Breast Cancer
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Kidney Cancer
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Prostate Cancer
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Cardiac Arrhythmia
9.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Cryoablation Devices Market, By End-Use
10.1. Cryoablation Devices Market, by End-Use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Ambulatory surgical centers
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Specialty Clinics
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Leisure & Entertainment
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Cryoablation Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-Use (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-Use (2020-2032)
Chapter 12. Company Profiles
12.1. Boston Scientific
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. MicroPort Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic Plc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. CooperSurgical Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. AtriCure Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Galil Medical
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. BVM Medical Limited
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. CPSI Biotech
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. HealthTronics, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IceCure Medical
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms